45 results
8-K
ENVB
Enveric Biosciences Inc
8 Jan 24
Cost Associated with Exit or Disposal Activities
4:42pm
future growth effectively; transition from third-party service providers supporting R&D efforts to internal science teams without any adverse impact
8-K
EX-99.1
ENVB
Enveric Biosciences Inc
13 Nov 23
Enveric Biosciences Reports Third Quarter 2023 Corporate and Financial Results
4:10pm
third-party service providers supporting R&D efforts to internal science teams without any adverse impact on Enveric’s ongoing and planned clinical
8-K
EX-99.1
tzk 8wvrcm
14 Aug 23
Enveric Biosciences Reports Second Quarter 2023 Corporate and Financial Results
8:00am
8-K
EX-99.1
tka4wu
7 Jun 23
Regulation FD Disclosure
8:00am
8-K
EX-99.1
p7x84txevdg4l
5 Jun 23
Enveric Biosciences Receives Notice of Allowance from USPTO for EVM301 Series of Drug Candidates
8:00am
8-K
EX-99.1
xrvk8as742b s2z5ff
30 May 23
Enveric Biosciences Announces Poster Presentation at Canadian Neuroscience Meeting 2023
8:00am
8-K
EX-99.1
8s0tbanbnn id1swe4dm
24 May 23
Regulation FD Disclosure
8:00am
8-K
EX-99.1
cnu een0bao
19 May 23
Enveric Biosciences to Participate in 2023 BIO International Convention in Boston
8:00am
8-K
EX-99.1
bghy3u
18 May 23
Enveric Biosciences Receives Notice of Allowance from USPTO for Novel Prodrug of Psilocin
8:00am
8-K
EX-99.1
vk5199ndwfzebbo ng6p
19 Jul 22
Enveric Biosciences Announces Formation of Scientific Advisory Board to Drive Further Growth of Next-Generation Mental Health Medicines
8:25am
425
d3rfko9
3 Sep 21
Business combination disclosure
5:26pm
8-K
qn9c52tf zj
3 Sep 21
Other Events
5:26pm